Introduction: The wholesale FOXO4 DRI peptide selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 binding, providing steady, substantial-purity components for growing older and most cancers exploration. day-to-day laboratory workflows frequently reveal a persistent obstacle: the slow and inefficient removal of senescent cells